Literature DB >> 738350

Plasma timolol levels after oral and intravenous administration.

O F Else, H Sorenson, I R Edwards.   

Abstract

The plasma kinetics of timolol administered orally and intravenously to 5 male subjects were examined. Bioavailability was reduced by 25% when the drug was taken orally. Mean plasma half-life after oral dosing was 4.86 h, and after intravenous administration it was 4.56 h; the difference was not significant. The volume of distribution was 3.5 1/k. It is suggested that timolol is little affected by the 'first pass effect', even though there is marked interindividual variation in availability and peak plasma level.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 738350     DOI: 10.1007/bf00716385

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Empirical equation for pharmacokinetic analysis of drug serum levels after oral application.

Authors:  H Engberg-Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

2.  Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.

Authors:  C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

3.  Physiological disposition and metabolism of timolol in man and laboratory animals.

Authors:  D J Tocco; A E Duncan; F A Delauna; H B Hucker; V F Gruber; W J Vandenheuvel
Journal:  Drug Metab Dispos       Date:  1975 Sep-Oct       Impact factor: 3.922

4.  The disposition of timolol in man.

Authors:  P Vermeij; M el-Sherbini-Schepers; P A van Zwieten
Journal:  J Pharm Pharmacol       Date:  1978-01       Impact factor: 3.765

5.  Duration of cardiac effects of timolol and propranolol.

Authors:  M R Achong; K M Piafsky; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

6.  Effect of timolol versus propranolol on hypertension and hemodynamics.

Authors:  W S Aronow; J Ferlinz; M Del Vicario; K Moorthy; J King; J Cassidy
Journal:  Circulation       Date:  1976-07       Impact factor: 29.690

7.  Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man.

Authors:  G Bodem; C A Chidsey
Journal:  Clin Pharmacol Ther       Date:  1973 Jan-Feb       Impact factor: 6.875

8.  Pharmacokinetics of pindolol in man.

Authors:  R Gugler; W Herold; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

9.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

Review 10.  Pharmacokinetics of propranolol: a review.

Authors:  D G Shand
Journal:  Postgrad Med J       Date:  1976       Impact factor: 2.401

  10 in total
  8 in total

Review 1.  Risk assessment of adverse pulmonary effects induced by adrenaline beta-receptor antagonists and rational drug dosage regimen based on receptor occupancy.

Authors:  Y Yamada; K Matsuyama; K Ito; Y Sawada; T Iga
Journal:  J Pharmacokinet Biopharm       Date:  1995-10

2.  Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects.

Authors:  R Richards; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1985-11       Impact factor: 4.335

3.  Pharmacokinetics of oral timolol studied by mass fragmentography.

Authors:  J B Fourtillan; P Courtois; M A Lefebvre; J Girault
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

4.  Absorption of ocular timolol.

Authors:  G Alvan; B Calissendorff; P Seideman; K Widmark; G Widmark
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

5.  Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.

Authors:  R Mäntylä; P Männistö; S Nykänen; A Koponen; U Lamminsivu
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.

Authors:  P H Hinderling; O Schmidlin; J K Seydel
Journal:  J Pharmacokinet Biopharm       Date:  1984-06

7.  Pharmacokinetics of intravenous timolol in patients with acute myocardial infarction and in healthy volunteers.

Authors:  J A Vedin; J K Kristianson; C E Wilhelmsson
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.